Phase 1 Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 75 years old at the time of screening, of any gender
- People who have been diagnosed with head and neck squamous cell carcinoma (a specific type of cancer affecting the head and neck area, but not the nasopharynx) confirmed through a tissue sample, and who are scheduled to receive radiation therapy after surgery
- People whose general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scoring system (called the ECOG scale, scores 0–2)
- People whose blood counts, liver function, kidney function, and heart function all meet certain minimum levels, as measured by blood tests taken within 7 days before starting treatment (confirm with trial site for exact values required)
- People who are able to understand the study information and are willing to sign a consent form before any study procedures begin
Who may not be able to join:
- People who have open wounds, skin inflammation, skin breakdown, or other skin problems in the area where the treatment would be applied, or who have tattoos or other permanent skin markings in that area that could make it hard to observe skin reactions
- People who have certain conditions affecting connective tissue or the skin throughout the body, such as lupus, dermatomyositis, scleroderma, or similar conditions
- People who have a known allergy to the study drug or any of its ingredients, or who have had a severe allergic reaction to any drug, food, or vaccine in the past
- People who have any serious uncontrolled illness — such as heart, lung, kidney, nerve, blood, digestive, or hormonal conditions — or a psychiatric condition such as depression or schizophrenia, that the study doctor believes could interfere with the trial
- People who have taken part in another clinical trial of a drug or medical device within the 3 months before screening
- People with a history of drug or alcohol misuse or addiction
- People who are pregnant or breastfeeding, or people (or their partners) who are planning to become pregnant at any point from screening until 12 months after the last dose of the study treatment
- People whom the study doctor considers unsuitable for the trial for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8618980606753
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Dose-Limiting Toxicities (DLTs); Incidence and Severity of Adverse Events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.